Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The Locations section now lists numerous participating sites across the United States, Canada, Australia, and various European and Asian countries.
    Difference
    5%
    Check dated 2025-12-19T10:16:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2 appears on the page. This seems to be a minor site version update with no visible changes to study content or user-facing elements.
    Difference
    0.0%
    Check dated 2025-11-27T22:53:50.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The Publications section now notes auto-fill from PubMed and the page revision is updated to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:29:49.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    Removed a general notice about government funding and NIH Clinical Center operations from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-13T16:51:57.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    No additions or deletions were detected; page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:19:26.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    Update of geographic region labels to Auvergne-Rhône-Alpes with city-level detail for Lyon (69008); replaces Rhône-Alpes references.
    Difference
    4%
    Check dated 2025-10-09T00:56:07.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.